This inventor holds 1 USPTO granted patent and 1 published patent application and 3 EPO patents. Top assignee: Neoproteomics Ab. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Timo Gemoll: Innovator in Cancer Diagnostics
Introduction
Timo Gemoll is a notable inventor based in Grossenbrode, Germany. He has made significant contributions to the field of cancer diagnostics, particularly through his innovative research and patents. His work focuses on the use of platelet-derived biomarkers for diagnosing cancer and assessing cancer progression.
Latest Patents
Timo Gemoll holds a patent titled "Platelet biomarkers in cancer diagnosis." This patent relates to the field of cancer diagnostics and emphasizes the importance of platelet-derived biomarkers in diagnosing cancer, determining cancer progression, and improving treatment outcomes. He has 1 patent to his name, showcasing his commitment to advancing medical science.
Career Highlights
Throughout his career, Timo has worked with reputable organizations, including Neoproteomics AB and the University of Lübeck. His experience in these institutions has allowed him to collaborate with other experts in the field and contribute to groundbreaking research in cancer diagnostics.
Collaborations
Timo has collaborated with notable colleagues such as Susanne Becker and Jens Habermann. These partnerships have enriched his research and expanded the impact of his work in the scientific community.
Conclusion
Timo Gemoll's contributions to cancer diagnostics through his innovative patent and collaborations highlight his role as a key figure in the field. His work continues to influence the development of effective diagnostic tools for cancer, ultimately benefiting patient care and treatment.